Expertise in
8
conditions

Dr. Vassilios A. Dimitropoulos

St Joseph Dermatology And Vein Clinic PLLC
Saint Joseph, MI
Expertise in
8
conditions
Specialties:Dermatology
Accepting New Patients
Offers Telehealth
Expertise in
8
conditions
OverviewInsuranceLocationsClinical Research

Overview

Vassilios Dimitropoulos is a Dermatologist in Saint Joseph, Michigan. Dr. Dimitropoulos is highly rated in 8 conditions, according to our data. His top areas of expertise are Multiple Familial Trichoepithelioma, Trichoepithelioma, Sebaceous Adenoma, and Syringoma. Dr. Dimitropoulos is currently accepting new patients.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in IL
Hospital Affiliations
Lakeland Hospital, St Joseph
University Of Illinois Hospital And Clinics
Languages Spoken
English
Greek
Spanish
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Priority Health
  •  Blue Cross Blue Shield
  •  McLaren Health
  •  Oscar
  •  UnitedHealthcare
View 2 More Insurances +

Locations

ST JOSEPH DERMATOLOGY AND VEIN CLINIC PLLC
2900 Niles Rd, Saint Joseph, MI 49085
773-334-3376
Other Locations
UNIVERSITY DERMATOLOGY AND VEIN CLINIC LLC
4700 N Marine Dr, Suite 220, Chicago, IL 60640
773-334-3376
ST JOSEPH DERMATOLOGY AND VEIN CLINIC PLLC
2500 Niles Rd, Suite 10a, Saint Joseph, MI 49085
269-428-5199
UNIVERSITY DERMATOLOGY AND VEIN CLINIC LLC
933 W Foster Ave, Chicago, IL 60640
773-334-3376
UNIVERSITY DERMATOLOGY AND VEIN CLINIC LLC
8110 Cass Ave, Darien, IL 60561
630-920-1900
UNIVERSITY DERMATOLOGY AND VEIN CLINIC LLC
4605 Golf Rd, Skokie, IL 60076
847-679-5199

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Active_not_recruiting
Publish Date: January 23, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

4 Total Publications

Reasons behind the ink.
Reasons behind the ink.
Journal: Cutis
Published: January 02, 2017
Similar Doctors
Expertise in
8
conditions
Dr. Peter A. Lio
Dermatology
Expertise in
8
conditions
Dr. Peter A. Lio
Dermatology

Medical Dermatology Associates Of Chicago Ltd

363 W Erie St, Suite 350, 
Chicago, IL 
 (61.3 mi)
312-922-1955
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Lio is a Dermatologist in Chicago, Illinois. Dr. Lio is highly rated in 8 conditions, according to our data. His top areas of expertise are Atopic Dermatitis, Perioral Dermatitis, Acne, and Rosacea. Dr. Lio is currently accepting new patients.

Expertise in
61
conditions
Dr. Amy S. Paller
Pediatrics | Dermatology
Expertise in
61
conditions
Dr. Amy S. Paller
Pediatrics | Dermatology

Pediatric Faculty Foundation Inc

225 E Chicago Ave, 
Chicago, IL 
 (60.4 mi)
312-227-6415
Languages Spoken:
English
See accepted insurances

Amy Paller is a Pediatrics specialist and a Dermatologist in Chicago, Illinois. Dr. Paller is highly rated in 61 conditions, according to our data. Her top areas of expertise are Atopic Dermatitis, Nonbullous Congenital Ichthyosiform Erythroderma, Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limbs Defects, Molluscum Contagiosum, and Gastrostomy.

Expertise in
23
conditions
Dr. Joerg Albrecht
Dermatology
Expertise in
23
conditions
Dr. Joerg Albrecht
Dermatology

Cook County

500 E 51st St, 
Chicago, IL 
 (61.6 mi)
312-572-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joerg Albrecht is a Dermatologist in Chicago, Illinois. Dr. Albrecht is highly rated in 23 conditions, according to our data. His top areas of expertise are Hidradenitis Suppurativa, Psoriasis, Cutaneous Lupus Erythematosus (CLE), and Genital Warts. Dr. Albrecht is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile